Remote Precision: SS Innovations' Telesurgery Console Extends Surgical Reach

Fort Lauderdale, FL – November 6, 2025 – SS Innovations International, Inc. (Nasdaq: SSII) achieved a significant milestone this week, successfully completing the first telesurgery using its newly developed SSi Mantra Tele Surgeon Console (TSC). The procedure, a robotic-assisted coronary artery bypass performed on a patient in Jaipur, India, was remotely guided by a surgeon operating from New Delhi – a distance of approximately 185 miles. This achievement isn’t just a technical feat; it represents a potential paradigm shift in how surgical expertise is delivered, particularly to underserved populations.

While robotic surgery has grown in prominence over the last decade, its adoption has been limited by high costs and the need for dedicated operating room infrastructure. SS Innovations aims to overcome these hurdles with the TSC – a compact, self-contained console designed for portability and ease of use. Unlike traditional robotic systems, the TSC can be deployed in a physician's office, potentially expanding access to specialized surgical care beyond major metropolitan centers.

“This successful telesurgery validates our vision of making robotic surgery more affordable and accessible,” stated a company representative. “The TSC significantly reduces the logistical and financial barriers to delivering advanced surgical expertise, particularly in remote or resource-constrained environments.”

Disrupting the Robotic Surgery Landscape

The global robotic surgery market is projected to reach $20 billion by 2027, with Intuitive Surgical’s da Vinci system currently dominating the field. However, new players like SS Innovations are beginning to challenge the status quo with innovative technologies and business models. The TSC’s compact design and portability offer a distinct competitive advantage, potentially attracting hospitals and clinics seeking to expand their robotic surgery capabilities without significant capital investment.

“The cost of entry into robotic surgery has been a major obstacle for many healthcare providers,” explains an industry analyst. “SS Innovations’ approach of creating a more streamlined and affordable system could disrupt the market and accelerate adoption, especially in developing countries.”

Beyond Logistics: The Technological Underpinnings
The success of the telesurgery hinged on more than just a compact console. The SSi Mantra system incorporates a range of advanced technologies, including high-definition 3D visualization, precise robotic arms, and a secure communication network. The TSC also features a virtual real-time image of the robotic patient side carts, and the ability for superimposition of 3D models of diagnostic imaging to provide surgeons with a detailed view of the surgical field.

“The precision and control offered by robotic surgery are crucial for complex procedures like coronary artery bypass,” notes a medical technology expert. “The TSC’s advanced features ensure that surgeons can maintain the same level of accuracy and control, even when operating remotely.”

The surgeon operating the TSC relied on a secure, low-latency communication network to transmit control signals and receive real-time video feedback from the surgical site. This is critical for maintaining the surgeon’s sense of presence and control during the procedure.

Addressing Regulatory Hurdles & Market Approval

The path to regulatory approval for telesurgery systems isn’t straightforward. SS Innovations navigated a complex landscape of regulations in both India and the United States, securing approval from the Central Drugs Standard Control Organization (CDSCO) in India and FDA clearance in the US. This required demonstrating the safety, efficacy, and reliability of the SSi Mantra system and the TSC.

The company is now actively seeking regulatory approvals in other key markets, including Europe and Japan, to expand the reach of its technology.

The Future of Remote Surgical Care

The successful telesurgery marks a pivotal moment for SS Innovations and a potential turning point for the field of remote surgical care. The company is planning to conduct further clinical trials and expand the range of procedures that can be performed using the TSC.

“We envision a future where specialized surgical expertise is available to everyone, regardless of their location,” says a company spokesperson. “The TSC is a crucial step towards achieving that goal.”

However, widespread adoption of telesurgery won’t be without challenges. Issues such as data security, liability, and the need for robust infrastructure will need to be addressed. Nevertheless, the potential benefits – increased access to care, improved patient outcomes, and reduced healthcare costs – are significant.

The implications extend beyond coronary artery bypass. Analysts predict the technology could be applied to a range of specialties, including trauma surgery, urology, and gynecology, opening up new possibilities for remote healthcare delivery.

“The democratization of surgical expertise is no longer a distant dream,” concludes an industry insider. “SS Innovations’ technology is bringing us closer to a future where everyone has access to the best possible care, regardless of where they live.”